Company intelligence / Profile preview
INmune Bio Inc.
Boca Raton, Florida, United Stateslinkedin.com ↗
- Ownership
- Public · INMB
- Employees
- ~50
- Development stage
- Phase 2
01
Overview
Currently conducting multiple clinical trials including a Phase 2 trial for Alzheimer's disease with 208 patients (overenrolled) with topline cognitive results expected in Q2 2025[10]. Phase I/II trial for INKmune in metastatic castration-resistant prostate cancer has completed Phase I portion with no safety issues and is now enrolling Phase II high dose cohort[6][9]. CORDStrom showed promising results in a Phase 2 randomized trial for recessive dystrophic epidermolysis bullosa[8].
- Therapeutic areas
- DermatologyOncologyPsychiatryNeurology
- Modalities
- Cell therapyDominant-Negative TNF technology
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Cell and Gene Therapy Catapult
04
Financials
- Market cap
- $61.4M
- Total revenue
- $0
- Enterprise value
- $44.4M
Beyond the preview
Go deeper on INmune Bio Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on INmune Bio Inc..